Panacos Pharmaceuticals Inc. Reports Fourth Quarter And Full Year Results for 2005; Company Updates Progress Toward Initiating PA-457 Phase 2b Clinical Trial

WATERTOWN, Mass.--(BUSINESS WIRE)--Feb. 14, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced its financial results for the quarter and year ended December 31, 2005.